Navigation Links
Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
Date:5/29/2008

SWARTZ CREEK, Mich., May 29 /PRNewswire/ -- Diplomat Specialty Pharmacy, a leader in specialty pharmacy services, disease management (DM) and drug therapy management (DTM) announced today that their specialty pharmacy was one of 3 sponsors of the National Managed Care Roundtable (NMCRT) held this month in Dallas, Texas. This forum brought 30 industry executives from top consulting and managed care organizations together to review and improve on the current offerings and directions of specialty pharmacy and other critical business segments.

"With our advisors high in the managed care hierarchy, their opinions carry weight in their organizations and within the managed care marketplace," stated Jim Smeeding, President of NMCRT. "I believe that Diplomat offered services that go above and beyond the usual expectations for a specialty pharmacy."

"Managed Care executives provided us with invaluable insights at the meeting. Their reviews will benefit us greatly as we continue to expand Diplomat on a national level," stated Phil Hagerman, President and CEO of Diplomat. "Consistent messages from the group included: the importance of patient care outcome reporting, the need for increased price transparency, the benefits of shared risk for disease management, and the need to maintain a high level of service to patients on specialty medications."

"The feedback from managed care organizations confirmed that specialty pharmacy is still a high priority within the pharmacy and medical benefits," stated Dr. Atheer Kaddis, Diplomat's Vice President of Managed Markets. "It also confirmed to us that there are very few, if any, successful care management models addressing kidney disease today. The programs presented by Diplomat Specialty Pharmacy to address specialty pharmacy and kidney disease were well received by managed care organizations and we are excited about future potential opportunities to work with managed care organizations in these priority areas."

Smeeding added that, "Diplomat was very well received by our advisors -- clearly there is an unmet need for managing these high cost, high acuity patients that Diplomat services. The feedback from our advisors should allow Diplomat to continue to expand their offerings with greater insights into what the marketplace demands and desires."

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is a privately held health care organization focusing on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company's Health Services division specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

About NMCRT

Established in 2006, National Managed Care Roundtable LLC (NMCRT) provides innovative, informational interchange programs to address the business and clinical issues of medical directors and pharmacy directors from health plans, pharmacy benefit management companies and physician groups. Typical sponsors include pharmaceutical companies, medical device, disease management and other companies offering products and services of interest to our advisors.

For more information contact:

Alecia Greilich

agreilich@diplomatpharmacy.com

810-720-4452


'/>"/>
SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
2. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
3. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
4. 60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
5. Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
6. West Pharmaceutical Services to Present at the 2008 UBS Global Specialty & Generic Pharmaceuticals Conference
7. Botaneco signs feasibility agreement with Croda to develop specialty crop oil formulation
8. Baxter Adds Recombinant Protein to Specialty Therapeutics Portfolio
9. Patient Treatment for Bipolar Disorder Varies Depending on Doctor Specialty; Well Designed Clinical Trials May Be The Answer
10. Pharmacyclics Announces It Received Nasdaq Notification
11. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017 Symic Bio, a biopharmaceutical company ... category of therapeutics, announced today the completion of enrollment ... artery disease. The trial will evaluate the safety and ... the reduction of restenosis following angioplasty. ... for SB-030," said Nathan Bachtell , M.D., Chief ...
(Date:2/24/2017)... Feb. 24, 2017 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced its unaudited financial results for the third quarter ... December 31, 2016. Third Quarter of Fiscal ... quarter of fiscal 2017 increased by 18.6% to RMB200.9 ...
(Date:2/24/2017)... Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a ... its financial results for the fourth quarter and fiscal year ... Total sales in the fourth quarter ... by 13.6% in USD terms to $77.6 million from $68.3 ... Gross profit increased by 13.3% to $46.8 million from $41.3 ...
(Date:2/24/2017)...  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company ... Opinion Leader event to highlight new clinical data that ... at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium and the ... held in-person and via live webcast on Tuesday, February ... at the Lotte New York Palace Hotel in ...
Breaking Biology Technology:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... by 2021 from $8.3 billion in 2016 at a ... to 2021. Report Includes - An overview of ... market trends, with data from 2015 and 2016, and ... - Segmentation of the market on the basis of ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
Breaking Biology News(10 mins):